JW Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
JW Pharmaceutical Stock Forecast and Price Target
According to esteemed experts, the average price target for JW Pharmaceutical to reach this year is ₩42000.00, with a potential upside of approximately 35.7%. This prediction is based on a high estimate of ₩45000.00 and a low estimate of ₩38000.00. If interested in A001060 stock, you may also want to consider its competitors.
35.70% Upside
JW Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's Price has decreased by 100.00%, from ₩42.49k to ₩0.00. For the next year, analysts are expecting Fair Value to reach ₩0.00 – an increase of 100.00%. Over the next six years, experts predict that Fair Value will grow by 100.00%.
JW Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's Revenue has grown by 25.03%, from ₩547.34B to ₩684.35B. For the next year, 0 analysts project JW Pharmaceutical's Revenue to drop by 10.83%, reaching ₩610.24B. By 2030, professionals believe that JW Pharmaceutical's Revenue will decrease by 10.21%, reaching ₩614.48B – a concerning trend for the company.
.jpg)
JW Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's Dividend per Share has grown from ₩325.00 to ₩356.94 – a 9.83% increase. According to 0 prominent analysts, JW Pharmaceutical's Dividend per Share will fall by 5.97% in the next year, reaching ₩335.64. By 2030, professionals believe that JW Pharmaceutical's Dividend per Share will decrease by 5.82%, reaching ₩336.17 – a concerning trend for the company.
JW Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's EBITDA has grown by 299.31%, rising from ₩19.37B to ₩77.33B. According to 0 major analysts, JW Pharmaceutical's EBITDA will fall by 45.77% in the next year, reaching ₩41.94B. Professionals believe that By 2030, JW Pharmaceutical's EBITDA will fall to ₩51.57B– a 33.31% decrease from its current value.
JW Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's EBIT has grown, rising from ₩-1.32B to ₩60.49B – a growth of 4672.29%. In the next year, 0 analysts estimate that JW Pharmaceutical's EBIT will decrease by 67.43%, reaching ₩19.70B. According to professional forecasts, in 2030, JW Pharmaceutical's EBIT will decrease by 31.72%, reaching ₩41.31B.
JW Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, JW Pharmaceutical's EPS has decreased by 100.00%, from ₩1304.90 to ₩0.00. For the next year, analysts are expecting EPS to reach ₩0.00 – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.
.jpg)